Autoimmune bullous diseases during pregnancy: Solving common and uncommon issues

International Journal of Women's Dermatology
Aikaterini PatsatsiDedee Murrell

Abstract

Autoimmune bullous diseases during pregnancy pose a therapeutic challenge for medical dermatologists. There are main concerns with regard to the regimen, dose, route of administration, and potential harm to the fetus. Many therapeutic options may be safe during pregnancy despite official classifications. Furthermore, there are always questions regarding management during the lactation period. Additionally, issues exist about male and female fertility and the time of discontinuation of certain medications before conception. In this article, we present an overview of the literature based on answers to these issues to solve common and uncommon management problems that arise about a spectrum of autoimmune bullous diseases before conception, as well as during pregnancy and the lactation period.

Citations

Oct 12, 2021·Experimental and Therapeutic Medicine·Raluca Anca BalanCornelia Amalinei

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent assay
contraception

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Società Italiana Di Dermatologia E Sifilografia
Emanuele Cozzani, Clara De Simone
Journal of the Royal College of Physicians of London
S H Wakelin, M M Black
The British Journal of Dermatology
T Hashimoto
Annales de dermatologie et de vénéréologie
L Vaillant, L Meunier
The Journal of Investigative Dermatology
Zhi Liu, David S Rubenstein
© 2021 Meta ULC. All rights reserved